First Trust Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $436M | Buy |
3,129,637
+1,683,586
| +116% | +$236M | 0.31% | 72 |
|
|
2025
Q4 | $177M | Sell |
1,446,051
-1,643,232
| -53% | -$200M | 0.13% | 192 |
|
|
2025
Q3 | $343M | Buy |
3,089,283
+1,874,508
| +154% | +$213M | 0.26% | 91 |
|
|
2025
Q2 | $135M | Sell |
1,214,775
-1,512,069
| -55% | -$161M | 0.11% | 225 |
|
|
2025
Q1 | $306M | Sell |
2,726,844
-235,377
| -8% | -$24.3M | 0.27% | 78 |
|
|
2024
Q4 | $274M | Buy |
2,962,221
+48,442
| +2% | +$4.36M | 0.24% | 103 |
|
|
2024
Q3 | $244M | Sell |
2,913,779
-1,077,079
| -27% | -$82.2M | 0.23% | 124 |
|
|
2024
Q2 | $274M | Sell |
3,990,858
-192,379
| -5% | -$12.8M | 0.28% | 81 |
|
|
2024
Q1 | $306M | Buy |
4,183,237
+65,509
| +2% | +$5.04M | 0.31% | 60 |
|
|
2023
Q4 | $334M | Sell |
4,117,728
-381,573
| -8% | -$29.7M | 0.36% | 41 |
|
|
2023
Q3 | $337M | Buy |
4,499,301
+454,229
| +11% | +$34.9M | 0.4% | 35 |
|
|
2023
Q2 | $312M | Sell |
4,045,072
-1,824,781
| -31% | -$146M | 0.35% | 44 |
|
|
2023
Q1 | $487M | Buy |
5,869,853
+2,339,008
| +66% | +$194M | 0.56% | 15 |
|
|
2022
Q4 | $303M | Sell |
3,530,845
-366,347
| -9% | -$29M | 0.36% | 42 |
|
|
2022
Q3 | $240M | Sell |
3,897,192
-574,230
| -13% | -$36.2M | 0.31% | 59 |
|
|
2022
Q2 | $276M | Sell |
4,471,422
-1,655,263
| -27% | -$102M | 0.34% | 51 |
|
|
2022
Q1 | $364M | Buy |
6,126,685
+3,114,535
| +103% | +$199M | 0.37% | 38 |
|
|
2021
Q4 | $219M | Buy |
3,012,150
+409,793
| +16% | +$28.2M | 0.21% | 120 |
|
|
2021
Q3 | $182M | Sell |
2,602,357
-226,890
| -8% | -$15.9M | 0.2% | 140 |
|
|
2021
Q2 | $195M | Buy |
2,829,247
+536,113
| +23% | +$35.8M | 0.21% | 117 |
|
|
2021
Q1 | $148M | Buy |
2,293,134
+31,017
| +1% | +$2M | 0.18% | 147 |
|
|
2020
Q4 | $132M | Sell |
2,262,117
-1,355,696
| -37% | -$81.8M | 0.17% | 142 |
|
|
2020
Q3 | $229M | Buy |
3,617,813
+380,737
| +12% | +$26.4M | 0.37% | 47 |
|
|
2020
Q2 | $249M | Buy |
3,237,076
+1,701,510
| +111% | +$130M | 0.43% | 31 |
|
|
2020
Q1 | $115M | Sell |
1,535,566
-48,629
| -3% | -$3.36M | 0.26% | 70 |
|
|
2019
Q4 | $103M | Sell |
1,584,195
-879,585
| -36% | -$57.3M | 0.18% | 122 |
|
|
2019
Q3 | $156M | Sell |
2,463,780
-361,927
| -13% | -$23.7M | 0.29% | 45 |
|
|
2019
Q2 | $191M | Buy |
2,825,707
+1,236,379
| +78% | +$81.3M | 0.36% | 37 |
|
|
2019
Q1 | $103M | Buy |
1,589,328
+255,863
| +19% | +$17M | 0.21% | 115 |
|
|
2018
Q4 | $83.4M | Sell |
1,333,465
-61,874
| -4% | -$4.32M | 0.2% | 106 |
|
|
2018
Q3 | $108M | Buy |
1,395,339
+415,500
| +42% | +$31.4M | 0.2% | 99 |
|
|
2018
Q2 | $69.4M | Sell |
979,839
-301,694
| -24% | -$21.3M | 0.14% | 141 |
|
|
2018
Q1 | $96.6M | Buy |
1,281,533
+171,189
| +15% | +$13.6M | 0.22% | 85 |
|
|
2017
Q4 | $79.5M | Sell |
1,110,344
-79,304
| -7% | -$6.02M | 0.19% | 101 |
|
|
2017
Q3 | $96.4M | Buy |
1,189,648
+336,724
| +39% | +$25.7M | 0.25% | 76 |
|
|
2017
Q2 | $60.4M | Buy |
852,924
+319,913
| +60% | +$21.3M | 0.16% | 128 |
|
|
2017
Q1 | $36.2M | Sell |
533,011
-21,793
| -4% | -$1.53M | 0.1% | 238 |
|
|
2016
Q4 | $39.7M | Buy |
554,804
+59,159
| +12% | +$4.4M | 0.12% | 186 |
|
|
2016
Q3 | $39.2M | Sell |
495,645
-48,653
| -9% | -$3.95M | 0.12% | 192 |
|
|
2016
Q2 | $45.4M | Sell |
544,298
-123,881
| -19% | -$11M | 0.14% | 139 |
|
|
2016
Q1 | $61.4M | Sell |
668,179
-860,133
| -56% | -$77.6M | 0.2% | 94 |
|
|
2015
Q4 | $155M | Sell |
1,528,312
-507,304
| -25% | -$52.8M | 0.4% | 29 |
|
|
2015
Q3 | $200M | Buy |
2,035,616
+263,726
| +15% | +$29.3M | 0.58% | 12 |
|
|
2015
Q2 | $207M | Buy |
1,771,890
+280,049
| +19% | +$30.6M | 0.54% | 15 |
|
|
2015
Q1 | $146M | Buy |
1,491,841
+85,660
| +6% | +$8.7M | 0.43% | 29 |
|
|
2014
Q4 | $133M | Sell |
1,406,181
-139,014
| -9% | -$14.4M | 0.45% | 16 |
|
|
2014
Q3 | $164M | Buy |
1,545,195
+421,228
| +37% | +$41.2M | 0.65% | 4 |
|
|
2014
Q2 | $93.2M | Sell |
1,123,967
-394,183
| -26% | -$30.7M | 0.39% | 23 |
|
|
2014
Q1 | $108M | Buy |
1,518,150
+230,265
| +18% | +$18.1M | 0.47% | 12 |
|
|
2013
Q4 | $96.7M | Sell |
1,287,885
-16,355
| -1% | -$1.14M | 0.47% | 15 |
|
|
2013
Q3 | $82M | Buy |
1,304,240
+242,747
| +23% | +$14.5M | 0.44% | 18 |
|
|
2013
Q2 | $54.4M | Buy |
+1,061,493
| New | +$55.3M | 0.35% | 26 |
|
Other funds holding GILD
VCM
VPM
First Trust Advisors's GILD Position: Q1 2026 in Review
First Trust Advisors increased its Gilead Sciences (GILD) stake by 116% in Q1 2026, buying an estimated $236M and bringing the position to 3,129,637 shares worth $436M. The position accounts for 0.31% of the portfolio, ranked #72.
First Trust Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $487M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- First Trust Advisors held 3,129,637 shares of Gilead Sciences worth $436M as of Q1 2026.
- First Trust Advisors bought 1,683,586 Gilead Sciences shares in Q1 2026, an estimated $236M.
- Gilead Sciences made up 0.31% of First Trust Advisors's portfolio in Q1 2026, its #72 holding.
- First Trust Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- First Trust Advisors's Gilead Sciences position peaked at $487M in Q1 2023.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.